Class ITerminatedD-1484-2020
Drug recall · August 12, 2020
Daptomycin for Injection recall
Why: Presence of Particulate Matter
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50
- Lots / codes
Lot #: 7605112, Exp 10/2021
- Quantity
- 18,480 vials
- Company
- Mylan Institutional LLC, Rockford, IL
- Distribution
- USA Nationwide
- Initiated
- July 7, 2020 · Voluntary: Firm initiated
- Classified
- August 4, 2020
- Reported
- August 12, 2020
- Ended
- January 27, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Daptomycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.